MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    A portable and distributable measure of temporal discrimination: an objective means for diagnosis of cervical dystonia.

    SR. Bostan, C. Fearon, M. Hutchinson, R. Reilly (Dublin, Ireland)

    Objective: Despite the high prevalence, devastating impact to patient quality of life and substantial cost burden on society, dystonia is still poorly understood. The lack…
  • 2023 International Congress

    Idiopathic Intracranial Hypertension as the presenting symptom in Wilson’s Disease: how is it possible?

    V. Mesquita, F. Rolim, A. Gomes, R. Carvalho, P. Matos, A. Marinho, N. Frota, F. Carvalho (Fortaleza, Brazil)

    Objective: To report a patient with Wilson’s disease (WD) who became symptomatic shortly after presenting Idiopathic Intracranial Hypertension (HII). Background: WD’s pleomorphic clinical phenotype remains…
  • 2023 International Congress

    Proposed model for the delivery of tertiary-care, interdisciplinary tremor evaluations.

    D. Roque, V. Krishna, M. Collins, J. Ferrall, N. Sharma (Chapel Hill, USA)

    Objective: To present the design and implementation of a proposed solution to handle tertiary-care evaluations for patients with tremor; providing comprehensive recommendations effectively communicated to…
  • 2023 International Congress

    Effect of lower level laser therapy for neurogenic or non-neurogenic overactive bladder

    T. Uchiyama, T. Yamamoto, R. Sakakibara, S. Kuwabara, H. Murai (Chiba, Japan)

    Objective: To evaluate the effect of lower level laser therapy for neurogenic or non-neurogenic overactive bladder (OAB) Background: There are many patients with OAB in…
  • 2023 International Congress

    RNF216–associated neurodegeneration: Is it a new NBIA disorder?

    NS. Sriram (Banglore, India)

    Objective: To describe certain unique clinical and imaging features in a patient with RNF216-associated neuro degeneration (RNF216-AN) Background: RNF216-AN, known as Gordon Holmes syndrome is…
  • 2023 International Congress

    Movement disorders at the National Institute of Neurology and Neurosurgery (INNN, Mexico City): most common diagnoses during 2022.

    D P. Romero Teran, A J. Hernández Medrano, D R. Aguila Godinez, A A. Herrera Ruiz, E C. Santiago Cruz, M. Medrano Delgado, M A. Ruiz Mafud, A Y. Regalado Mustafá, M F. Medina Perez, G I. Cerda Hernández, M. Rodriguez Violante, A. Cervantes Arriaga, G. Hernandez Armesto, A. Abundes Corona, A. Dominguez Garcia, K. Talavera Lagunas (CDMX, Mexico)

    Objective: To provide data about the movement disorders (MD) outpatient consultation (OC) service from the INNN, Mexico City during 2022. Background: The INNN, inaugurated in…
  • 2023 International Congress

    Comparative Effects of Medical Treatment and Tension Deactivation Via Electromyography Biofeedback Intervention to Improve Maximum Mouth Opening in Individuals With Bruxism

    MYA. Amine, U. El-Dakrory (Giza, Egypt)

    Objective: comparing the effects of muscle relaxants and NSAIDs with EMG biofeedback in improving maximum mouth opening in bruxism. Background: Bruxism is an extrapyramidal system…
  • 2023 International Congress

    Acute movement disorder with atypical topography. Acute hemichorea secondary to cortical stroke.

    CJ. de Miguel-Sánchez, G. Lafuente-Gómez, R. Leal-Hidalgo, M. González-Sánchez (Madrid, Spain)

    Objective: We present a case of acute hemichorea secondary to cortical infarction in the MCA territory. Background: Acute abnormal movements secondary to stroke occur in…
  • 2023 International Congress

    Effect of the 5-HT2A/2C inverse agonist nelotanserin on dyskinesia in the MPTP-lesioned marmoset

    C. Kwan, I. Frouni, D. Bédard, S. Nuara, J. Gourdon, P. Huot (Montreal, Canada)

    Objective: To determine the effect of the serotonin 2A/2C (5-HT2A/2C) receptor inverse agonist nelotanserin on dyskinesia in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-lesioned marmoset. Background: Nelotanserin is a…
  • 2023 International Congress

    The role of Anti-Ribosomal P antibody in Autoimmune cerebellar ataxia

    V. Vysakha (Trivandrum, India)

    Objective: To describe the clinical features and presentation of an auto-immune cerebellar ataxia with asymmetric Holmes tremor and its therapeutic response. Background: Autoimmune cerebellar ataxia…
  • « Previous Page
  • 1
  • …
  • 68
  • 69
  • 70
  • 71
  • 72
  • …
  • 186
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley